Physician profile
Daniel John Womac
NPI 1316144645
$11,679.74
in general payments reported to CMS, 2019-2025
33 companies · $1,384 in 2025
The $1,384 reported for 2025 was more than what 79% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,997 · 2020: $931 · 2021: $1,072 · 2022: $1,458 · 2023: $1,783 · 2024: $1,055 · 2025: $1,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,221.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,617.70 | 2023-2025 | Alloderm, Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps |
| Allergan, INC. | $1,945.15 | 2019-2022 | |
| Mentor Worldwide LLC | $1,588.87 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Sientra, INC. | $789.73 | 2019-2022 | |
| Smith+Nephew, INC. | $663.86 | 2019-2024 | Grafix Pl, Stravix, Collagenase Santyl |
| Polarityte, INC. | $512.06 | 2019 | |
| Axogen | $486.30 | 2019-2025 | |
| Baxter Healthcare | $454.04 | 2019-2023 | Artiss |
| Integra Lifesciences Corporation | $418.26 | 2019-2023 | Durasorb Monofilament Mesh |
| Stryker Corporation | $268.95 | 2023-2025 | Spy-Phi System, Molli |
| Musculoskeletal Transplant Foundation INC. | $259.00 | 2019-2021 | |
| Tela Bio, INC. | $189.34 | 2019 | |
| Acera Surgical, INC. | $171.89 | 2024-2025 | Restrata Wound Matrix |
| Sonavex, INC. | $169.16 | 2020 | |
| Organogenesis INC. | $145.29 | 2019-2025 | Puraply Wound Matrix |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $137.03 | 2019 | |
| Polynovo North America LLC | $132.24 | 2020 | |
| Kls-Martin L.P. | $114.70 | 2020 | |
| Molnlycke Health Care US, LLC | $101.18 | 2019 | |
| Avanos Medical | $63.71 | 2019 | |
| Davol INC. | $62.10 | 2022-2025 | Phasix Mesh |
| Kci USA, INC. | $57.39 | 2019-2020 | |
| Convatec INC. | $54.40 | 2019-2020 | |
| Depuy Synthes Sales INC. | $44.00 | 2022 | |
| Zyla Life Sciences, INC. | $43.98 | 2019-2020 | |
| Medtronic, INC. | $40.22 | 2025 | Transorb |
| Motiva USA, LLC | $36.37 | 2025 | |
| W. L. Gore & Associates, INC. | $30.32 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Medela LLC | $19.55 | 2022 | |
| Innovation Technologies INC | $18.33 | 2024 | Irrisept |
| Coopersurgical, INC. | $16.45 | 2019 | |
| Kerecis Limited | $14.22 | 2019 | |
| Galderma Laboratories, L.P. | $13.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Womac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.